Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 272

1.

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GY; AFCAS Study Group.

Am Heart J. 2017 Aug;190:86-93. doi: 10.1016/j.ahj.2017.05.016. Epub 2017 Jun 3.

PMID:
28760217
2.

Traffic is a major source of atmospheric nanocluster aerosol.

Rönkkö T, Kuuluvainen H, Karjalainen P, Keskinen J, Hillamo R, Niemi JV, Pirjola L, Timonen HJ, Saarikoski S, Saukko E, Järvinen A, Silvennoinen H, Rostedt A, Olin M, Yli-Ojanperä J, Nousiainen P, Kousa A, Dal Maso M.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7549-7554. doi: 10.1073/pnas.1700830114. Epub 2017 Jul 3.

3.

Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.

Nammas W, Pietilä M, Romppanen H, Sia J, DeBelder A, Karjalainen PP.

Scand Cardiovasc J. 2017 Jun 30:1-7. doi: 10.1080/14017431.2017.1346278. [Epub ahead of print]

PMID:
28666394
4.

Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: Cardiac filling pressures, pulmonary congestion and mortality.

Öhman J, Harjola VP, Karjalainen P, Lassus J.

Eur Heart J Acute Cardiovasc Care. 2017 May 1:2048872617708974. doi: 10.1177/2048872617708974. [Epub ahead of print]

PMID:
28485200
5.
6.

Percutaneous revascularization of coronary chronic total occlusion: Toward a reappraisal of the available evidence.

Karjalainen PP, Nammas W.

J Cardiol. 2017 Jun;69(6):799-807. doi: 10.1016/j.jjcc.2016.12.006. Epub 2017 Mar 18. Review.

PMID:
28325520
7.

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.

Jaguszewski M, Aloysius R, Wang W, Bezerra HG, Hill J, De Winter RJ, Karjalainen PP, Verheye S, Wijns W, Lüscher TF, Joner M, Costa M, Landmesser U.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):489-499. doi: 10.1016/j.jcin.2016.11.040.

PMID:
28279316
8.

Physical activity, sedentary behaviour, and socioeconomic status among Finnish girls and boys aged 6-8 years.

Lampinen EK, Eloranta AM, Haapala EA, Lindi V, Väistö J, Lintu N, Karjalainen P, Kukkonen-Harjula K, Laaksonen D, Lakka TA.

Eur J Sport Sci. 2017 May;17(4):462-472. doi: 10.1080/17461391.2017.1294619. Epub 2017 Mar 1.

PMID:
28276910
9.

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence.

Nammas W, Koistinen J, Paana T, Karjalainen PP.

Ann Med. 2017 Aug;49(5):384-395. doi: 10.1080/07853890.2017.1282168. Epub 2017 Feb 10.

PMID:
28276870
10.

Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GYH; AFCAS Study Group.

Clin Res Cardiol. 2017 Jun;106(6):420-427. doi: 10.1007/s00392-016-1071-0. Epub 2017 Jan 11.

11.

Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial.

Karjalainen PP, Nammas W, Kervinen K, de Belder A, Rivero-Crespo F, Ylitalo A, Airaksinen JK.

J Interv Cardiol. 2017 Apr;30(2):114-123. doi: 10.1111/joic.12357. Epub 2016 Dec 7.

PMID:
27925308
12.

Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).

Karjalainen PP, Niemelä M, Laine M, Airaksinen JK, Ylitalo A, Nammas W.

Am J Cardiol. 2017 Feb 1;119(3):345-350. doi: 10.1016/j.amjcard.2016.09.057. Epub 2016 Nov 1.

PMID:
27887689
13.

Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.

Varho V, Nammas W, Kiviniemi TO, Sia J, Romppanen H, Pietilä M, Airaksinen JK, Karjalainen PP.

Int J Cardiol. 2017 Jan 15;227:194-200. doi: 10.1016/j.ijcard.2016.11.173. Epub 2016 Nov 9.

PMID:
27839810
14.

Nutritive sucking induces age-specific EEG-changes in 0-24 week-old infants.

Lehtonen J, Valkonen-Korhonen M, Georgiadis S, Tarvainen MP, Lappi H, Niskanen JP, Pääkkönen A, Karjalainen PA.

Infant Behav Dev. 2016 Nov;45(Pt A):98-108. doi: 10.1016/j.infbeh.2016.10.005. Epub 2016 Oct 26.

15.

Renal sympathetic denervation for treatment of patients with atrial fibrillation: Reappraisal of the available evidence.

Nammas W, Airaksinen JK, Paana T, Karjalainen PP.

Heart Rhythm. 2016 Dec;13(12):2388-2394. doi: 10.1016/j.hrthm.2016.08.043. Epub 2016 Aug 30.

PMID:
27590432
16.

Heavy Duty Diesel Exhaust Particles during Engine Motoring Formed by Lube Oil Consumption.

Karjalainen P, Ntziachristos L, Murtonen T, Wihersaari H, Simonen P, Mylläri F, Nylund NO, Keskinen J, Rönkkö T.

Environ Sci Technol. 2016 Nov 15;50(22):12504-12511. Epub 2016 Oct 26.

PMID:
27734664
17.

Titanium-nitride-oxide-coated coronary stents: insights from the available evidence.

Karjalainen PP, Nammas W.

Ann Med. 2017 Jun;49(4):299-309. doi: 10.1080/07853890.2016.1244353. Epub 2016 Nov 12.

PMID:
27690662
18.

Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.

Nammas W, Airaksinen JKE, Romppanen H, Sia J, de Belder A, Karjalainen PP.

Angiology. 2017 Jul;68(6):513-518. doi: 10.1177/0003319716664266. Epub 2016 Aug 19.

PMID:
27543565
19.

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.

Nammas W, de Belder A, Niemelä M, Sia J, Romppanen H, Laine M, Karjalainen PP.

Eur J Intern Med. 2017 Jan;37:43-48. doi: 10.1016/j.ejim.2016.07.027. Epub 2016 Aug 5.

PMID:
27499178
20.

Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.

Karjalainen PP, Nammas W, Ylitalo A, de Bruyne B, Lalmand J, de Belder A, Rivero-Crespo F, Kervinen K, Airaksinen JK.

Int J Cardiol. 2016 Nov 1;222:275-80. doi: 10.1016/j.ijcard.2016.07.267. Epub 2016 Aug 1.

PMID:
27497110

Supplemental Content

Loading ...
Support Center